The Role of AI and Machine Learning in 3D Bioprinting Market Growth

The 3D bioprinting market is projected to experience significant growth over the next decade. With an estimated market valuation of USD 2.24 billion by 2024, the demand for 3D bioprinting is anticipated to soar to USD 6.82 billion by 2034, advancing at a Compound Annual Growth Rate (CAGR) of 11.8% from 2024 to 2034.

Significant progress in tissue engineering and regenerative medicine is credited for this notable expansion. In addition, the market is supported by growing investments in bioprinting technology and enhanced partnerships among healthcare providers, biotech businesses, and research institutes. The 3D bioprinting sector is expanding because to the increasing desire for customized medicine, which presents novel approaches for treating patients based on their unique needs.

The global 3D bioprinting market presents substantial opportunities for stakeholders across the healthcare and biotechnology sectors. As the technology continues to evolve, it is expected to revolutionize the fields of tissue engineering, regenerative medicine, and personalized healthcare.

Request a Sample Copy of This – Report Now

Key Takeaways

The 3D cell culture method is an effective alternative to overcome the existing organ donation shortage crisis faced by the world. According to the U.S. Government Information on Organ Donation and Transplantation, more than 113,000 people are on the waiting list as of July 2019. The unavailability of organs for transplant cause the death of 20 patients per day.
3D bioprinting can be a significant solution to the organ transplant waiting for crisis so that patients can receive an organ for transplant in time. 3D bioprinting technology has been used in regenerative medicine through printed devices such as 3D printing surgical instruments and prosthetics. Currently, researchers are testing out bio-ink as a way of printing cartilage, bones, and vital organs.
The ongoing research on regenerative medicine and advancements in tissue engineering are focusing on the regeneration of damaged tissues and organs with the help of 3D bioprinting. A group of scientists from Tel Aviv University developed a fully vascularized heart using 3D bioprinting by using fat tissue cells from a donor. This has led to the development of 3D bio-printed heart tissue. Scientists from Swansea University UK developed a 3D bioprinting process by using regenerative and durable biomaterial.

Competitive Landscape

The key players operating in the 3D bioprinting market are currently strengthening their materials portfolio. This is mainly done by adding new metals to the product portfolio. Apart from that, technological upgradation is also being done by the key players to simplify the processes. 3D Systems, GE Healthcare, ExOne, Electro Optical Systems, Renishaw plc, and others are the top player of the 3D bioprinting market.

More Insights into the 3D bioprinting market

The Asia Pacific region is expected to dominate the global 3D bioprinting market over the assessment period. As per FMI analysis, developing economies like India, China, and Japan are expected to make massive contributions, owing to massive investment in the healthcare sector. Additionally, increasing disposable income is also expected to surge the market share in this region.

China is expected to generate reasonable revenue in the global market since the Chinese government is offering to fund the establishment of a manufacturing facility for the production of biomaterials and studying 3D-printed organs and tissues. In 2015, Materialise NV. opened its first pediatric 3D medical research facility at the Children’s Medical Center, in Shanghai, China. The focus was on pediatric 3D modeling and medical imaging and 3D fabrication.

3D Bioprinting Market Segmentation

By Technology: